Patents by Inventor Robert Lathrop

Robert Lathrop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150209429
    Abstract: The present disclosure generally relates to pharmaceutical corticosteroid compositions, and methods of making the same.
    Type: Application
    Filed: June 3, 2014
    Publication date: July 30, 2015
    Inventors: Robert Lathrop, David Wade Osborne
  • Publication number: 20140357607
    Abstract: The present disclosure generally relates to pharmaceutical corticosteroid compositions, and methods of making the same.
    Type: Application
    Filed: June 3, 2014
    Publication date: December 4, 2014
    Inventors: Robert Lathrop, David Wade Osborne
  • Publication number: 20140004552
    Abstract: The invention concerns reagent delivery system for an apparatus for processing of biological samples arranged on microscope slides, comprising a reagent section having one or more reagent containers; a slide section in which at least one microscope slide is arranged; a probe for dispensing a portion of reagent onto a predetermined microscope slide, and means for handling the probe. The probe comprises a continuous prove tubing element extending through a rigid probe member and connecting the probe tip to a pneumatic pressure regulation device. The reagent containers are adapted for cooperation with the probe tip. In this manner a high though-put and a very low carry over of fluid residues is achieved since there is no assembled parts making up the inside volume of the probe in which the fluid may be retained.
    Type: Application
    Filed: June 17, 2013
    Publication date: January 2, 2014
    Inventors: John Favuzzi, Jonathan Sweda, Lauren Bland, Merrit Martin, Robert Lathrop, John Van Bosch, Kristopher Buchanan
  • Publication number: 20130002456
    Abstract: A communications module for conveying information to the driver of a truck is provided. The module is designed to reside in the cab of a truck that is carrying a full truckload of cargo. The communications module includes a user interface such as a screen. The communications module also has a modem. The modem is used for communicating with a host trucking management system through a wireless communications system. The communications module has a vehicle navigation system. The vehicle navigation system communicates with a GPS satellite system to generate maps on the user interface. The navigation system allows the driver to refer to a map on a screen for driving directions en route to a cargo pick-up location or other location. Further, the communications module includes a processing unit that is programmed to receive cargo delivery data sets from the host trucking management system.
    Type: Application
    Filed: August 30, 2012
    Publication date: January 3, 2013
    Inventors: Max L. Fuller, Kenneth W. Crane, Robert Lathrop, Scott Davison
  • Patent number: 8285611
    Abstract: A method for transporting cargo using a truck is provided. Preferably, the method is used in connection with full truckload operations. The method generally includes powering up a communications module residing within a cab of the truck. The communications module comprises a vehicle navigation system, a modem for receiving telecommunications signals, a processing unit for associating instructions for cargo delivery locations with geo-positioning coordinates, and a user interface. The method further includes receiving a cargo delivery data set at the communications module. The data set is sent from a host trucking management system. The data set provides at least a first cargo delivery location for the driver. The method then includes the driver acknowledging receipt of the first cargo delivery location through the user interface. Acknowledgment of receipt of the first cargo delivery location causes a signal to be sent from the communications module to the host trucking management system.
    Type: Grant
    Filed: December 29, 2009
    Date of Patent: October 9, 2012
    Inventors: Max L. Fuller, Kenneth W. Crane, Robert Lathrop, Scott Davison
  • Publication number: 20110009481
    Abstract: The invention relates to a medicament containing a compound of general formula (I), where R1=independently, a straight or branched, saturated, singly- or multiply-unsaturated, optionally substituted C11-C21 alkyl, alkylene or alkinyl group, preferably a C11-C15 alkyl, alkylene or alkinyl group, particularly a C11-C13 alkyl, alkylene or alkinyl group, most preferably a C13 alkyl group, R2=independently, a straight or branched C1-C8 alkyl, alkylene or alkinyl group, preferably a C1-C6 alkyl, alkylene or alkinyl group, in particular a C2-C4 alkyl, alkylene or alkinyl group, most preferably a C3 alkyl group, a —[CH2—(CH2)m-O]nH group with n=1 to 10, preferably n=1 to 5, to m=1 to 5, preferably m=1 to 3, a —CH2—[CH—(OH)]p[CH2—R3]- group, where R3=independently H or OH, p=1 to 7, preferably p=1 to 4, a pentose group or a hexose group, as therapeutically active agent, alone or in combination with one or several further pharmaceutical agents as a combination preparation for the treatment of viral skin diseases and/or
    Type: Application
    Filed: September 21, 2010
    Publication date: January 13, 2011
    Applicant: MediGene AG
    Inventors: Yunik Chang, Robert Lathrop, Erwin Böhm, Irene Gander-Meisterernst, Regina Greger, Johanna Holldack, Ulrich Moebius
  • Patent number: 7858662
    Abstract: The invention relates to a medicament containing a compound of general formula (1), where R1=independently, a straight or branched, saturated, singly- or multiply-unsaturated, optionally substituted C11-C21 alkyl, alkylene or alkynyl group, preferably a C11-C15 alkyl, alkylene or alkynyl group, particularly a C11-C13 alkyl, alkylene or alkynyl group, most preferably a C13 alkyl group, R2=independently, a straight or branched C1-C8 alkyl, alkylene or alkynyl group, preferably a C1-C6 alkyl, alkylene or alkynyl group, in particular a C2-C4 alkyl, alkylene or alkynyl group, most preferably a C3 alkyl group, a —[CH2—(CH2)m—O]nH group with n=1 to 10, preferably n=1 to 5, m=1 to 5, preferably m=1 to 3, a —CH2—[CH—(OH)]p[CH2—(R3)]— group, where R3=independent H or OH, p=1 to 7, preferably p=1 to 4, a pentose group or a hexose group, as therapeutically active agent, alone or in combination with one or several further pharmaceutical agents as a combination preparation for the treatment of viral skin diseases and/or tu
    Type: Grant
    Filed: November 18, 2002
    Date of Patent: December 28, 2010
    Assignee: MediGene AG
    Inventors: Yunik Chang, Robert Lathrop, Erwin Böhm, Irene Gander-Meisterernst, Regina Greger, Johanna Holldack, Ulrich Moebius
  • Patent number: 7758809
    Abstract: The present invention concerns a method and an apparatus for automatic staining of at least one tissue sample accommodated on a slide by applying reagents. The system may include at least one slide provided in a slide rack, a fluid containment element, a slide holder, a vertical slide positioner to pivot the slides to a vertical position, and a slide immerser element to immerse the vertical slide into a fluid containment element or even a dip tank. By pivoting the slides from a horizontal to a vertical position, an automated method and apparatus for carrying out a pretreatment in an automated staining apparatus may be provided. The pivoting of slides may ensure an appropriate orientation of the slides for both the pretreatment and the staining processes.
    Type: Grant
    Filed: December 3, 2009
    Date of Patent: July 20, 2010
    Assignee: Dako Cytomation Denmark A/S
    Inventors: John Favuzzi, Benno Guggenheimer, Jeff Rau, Marc Key, Robert Lathrop, Rosanne Welcher
  • Publication number: 20100169199
    Abstract: A method for transporting cargo using a truck is provided. Preferably, the method is used in connection with full truckload operations. The method generally includes powering up a communications module residing within a cab of the truck. The communications module comprises a vehicle navigation system, a modem for receiving telecommunications signals, a processing unit for associating instructions for cargo delivery locations with geo-positioning coordinates, and a user interface. The method further includes receiving a cargo delivery data set at the communications module. The data set is sent from a host trucking management system. The data set provides at least a first cargo delivery location for the driver. The method then includes the driver acknowledging receipt of the first cargo delivery location through the user interface. Acknowledgment of receipt of the first cargo delivery location causes a signal to be sent from the communications module to the host trucking management system.
    Type: Application
    Filed: December 29, 2009
    Publication date: July 1, 2010
    Inventors: Max L. Fuller, Kenneth W. Crane, Robert Lathrop, Scott Davison
  • Publication number: 20100081167
    Abstract: The present invention concerns a method and an apparatus for automatic staining of at least one tissue sample accommodated on a slide by applying reagents. The system may include at least one slide provided in a slide rack, a fluid containment element, a slide holder, a vertical slide positioner to pivot the slides to a vertical position, and a slide immerser element to immerse the vertical slide into a fluid containment element or even a dip tank. By pivoting the slides from a horizontal to a vertical position, an automated method and apparatus for carrying out a pretreatment in an automated staining apparatus may be provided. The pivoting of slides may ensure an appropriate orientation of the slides for both the pretreatment and the staining processes.
    Type: Application
    Filed: December 3, 2009
    Publication date: April 1, 2010
    Inventors: John Favuzzi, Benno Guggenheimer, Jeff Rau, Marc Key, Robert Lathrop, Rosanne Welcher
  • Patent number: 7648678
    Abstract: The present invention concerns a method and an apparatus for automatic staining of at least one tissue sample accommodated on a slide by applying reagents. The system may include at least one slide provided in a slide rack, a fluid containment element, a slide holder, a vertical slide positioner to pivot the slides to a vertical position, and a slide immerser element to immerse the vertical slide into a fluid containment element or even a dip tank. By pivoting the slides from a horizontal to a vertical position, an automated method and apparatus for carrying out a pretreatment in an automated staining apparatus may be provided. The pivoting of slides may ensure an appropriate orientation of the slides for both the pretreatment and the staining processes.
    Type: Grant
    Filed: December 8, 2003
    Date of Patent: January 19, 2010
    Assignee: DAKO Denmark A/S
    Inventors: John Favuzzi, Benno Guggenheimer, Jeff Rau, Marc Key, Robert Lathrop, Rosanne Welcher
  • Publication number: 20090030060
    Abstract: The present invention provides a buffered non-flowing composition suitable for the treatment of bacterial vaginosis. The composition includes metronidazole in a concentration of about 0.50% (w/w) to about 1.50% (w/w). The metronidazole is present together with a buffer system in a physiologically tolerable medium. The buffer system provides an acidic buffered pH value for the composition in the range of about 5.0 to about 6.0. The present invention also provides for a method for inhibiting a microorganism. The method includes contacting a microorganism with an effective amount of the composition of the present invention, for a period of time effective to inhibit the microorganism. The present invention also provides for a method for treating bacterial vaginosis in a human patient. The method includes intravaginal administration to a patient in need of such treatment an effective amount of the composition the present invention.
    Type: Application
    Filed: July 18, 2008
    Publication date: January 29, 2009
    Applicant: Tolmar, Inc.
    Inventors: Matthew Ebmeier, Robert Lathrop
  • Publication number: 20070231358
    Abstract: The present invention provides a buffered non-flowing composition suitable for the treatment of bacterial vaginosis. The composition includes metronidazole in a concentration of about 0.50% (w/w) to about 1.50% (w/w). The metronidazole is present together with a buffer system in a physiologically tolerable medium. The buffer system provides an acidic buffered pH value for the composition in the range of about 5.0 to about 6.0. The present invention also provides for a method for inhibiting a microorganism. The method includes contacting a microorganism with an effective amount of the composition of the present invention, for a period of time effective to inhibit the microorganism. The present invention also provides for a method for treating bacterial vaginosis in a human patient. The method includes intravaginal administration to a patient in need of such treatment an effective amount of the composition the present invention.
    Type: Application
    Filed: June 13, 2007
    Publication date: October 4, 2007
    Inventors: Matthew Ebmeier, Robert Lathrop
  • Publication number: 20060241650
    Abstract: An apparatus and methods for delivering ocular implants or microimplants. The apparatus is ergonomically designed for ease of use, and a simple manual depression of an actuator produces proportional movement of a linkage causing the implant or microimplant to be ejected through a cannula disposed at the desired location in the eye. Small gauge cannulas are provided for self-sealing methods of delivery.
    Type: Application
    Filed: June 26, 2006
    Publication date: October 26, 2006
    Applicant: Allergan, Inc.
    Inventors: David Weber, Ingrid Kane, Mike Rehal, Robert Lathrop, Kenny Aptekarev, Jeffrey Etter
  • Publication number: 20060204526
    Abstract: The present invention relates to a topical, emulsive composition containing Dapsone or its derivative. The inventive composition incorporates emollients and Dapsone or its derivative in a stable emulsion. The stability is achieved through the use of a combination of certain surfactant mixtures and an enhancer providing solubility of the Dapsone.
    Type: Application
    Filed: February 13, 2006
    Publication date: September 14, 2006
    Inventors: Robert Lathrop, David Osborne
  • Publication number: 20060148063
    Abstract: A method and apparatus for continuous workflow processing of biological samples. In one embodiment, the appratus includes a probe for dispensing one or more reagents from one or more reagent containers onto one or more biological sample carriers. The method and apparatus includes processing each biological sample according to a respective sequence of protocol steps which may be ordered by a scheduler protocol. The method and apparatus also includes network capability for connectivity with additional equipment for receiving or transmitting pertinent data via the network.
    Type: Application
    Filed: September 16, 2005
    Publication date: July 6, 2006
    Inventors: John Fauzzi, Marc Key, Robert Lathrop, Gordon Feingold
  • Publication number: 20060105359
    Abstract: The present invention concerns a method and apparatus for automatic processing a biological sample on a carrier, perhaps robotically, by applying predetermined amounts of reagents in a predetermined sequence according to a processing protocol, the processing including pre-treatment steps, under the control of an adaptive processing control system using a sample process parameter input that may be independent and an independent process parameter memory that does not interrupt process operation when being used, such that samples may be added or removed without interrupting the processing of other samples. Also included is an image capture function for sample and reagent identification and process monitoring, as well as temperature regulation and environmental control functions.
    Type: Application
    Filed: June 20, 2005
    Publication date: May 18, 2006
    Applicant: DakoCytomation Denmark A/S
    Inventors: John Favuzzi, Kristopher Buchanan, Michael Barber, Loren Bland, Dawn Rohrbacker, Robert Clark, Gordon Feingold, Benno Guggenheimer, Marc Key, Merritt Martin, Robert Lathrop, Jeffery Rau, Jonathan Sweda, Douglas Sweet, John Van Bosch, Lars Winther, Rosanne Welcher
  • Publication number: 20060093675
    Abstract: The present invention provides a buffered non-flowing composition suitable for the treatment of bacterial vaginosis. The composition includes metronidazole in a concentration of about 0.50% (w/w) to about 1.50% (w/w). The metronidazole is present together with a buffer system in a physiologically tolerable medium. The buffer system provides an acidic buffered pH value for the composition in the range of about 5.0 to about 6.0. The present invention also provides for a method for inhibiting a microorganism. The method includes contacting a microorganism with an effective amount of the composition of the present invention, for a period of time effective to inhibit the microorganism. The present invention also provides for a method for treating bacterial vaginosis in a human patient. The method includes intravaginal administration to a patient in need of such treatment an effective amount of the composition the present invention.
    Type: Application
    Filed: October 29, 2004
    Publication date: May 4, 2006
    Inventors: Mathew Ebmeier, Robert Lathrop
  • Publication number: 20060078599
    Abstract: The present invention provides a non-water soluble, film-forming composition which adheres to body tissue and forms a pharmaceutical carrier to provide localized delivery of an antifungal agent to a treatment site. The composition will typically include: (a) an alkyl cellulose; (b) a hydroxyalkyl cellulose; (c) a pharmaceutically acceptable polar protic solvent; (d) an antifungal agent selected from the group of naftifine, ciclopirox, terbinafine, pharmaceutically acceptable salts thereof, and combinations thereof; (e) an glycol ether; (f) an antipruritic agent selected from the group of camphor, menthol, butamben picrate, metacresol, benzyl alcohol, camphorated metacresol, juniper tar, phenol, phenolate sodium, resorcinol, camphorated metacresol, carbolic acid, and combinations,; and (g) a solubility enhancing agent, a surfactant, a wetting agent, or a combination thereof.
    Type: Application
    Filed: October 12, 2004
    Publication date: April 13, 2006
    Inventors: Mathew Ebmeier, Robert Lathrop
  • Publication number: 20050203542
    Abstract: An apparatus and methods for delivering ocular implants or microimplants. The apparatus is ergonomically designed for ease of use, and a simple manual depression of an actuator produces proportional movement of a linkage causing the implant or microimplant to be ejected through a cannula disposed at the desired location in the eye. Small gauge cannulas are provided for self-sealing methods of delivery.
    Type: Application
    Filed: August 13, 2004
    Publication date: September 15, 2005
    Applicant: ALLERGAN, INC.
    Inventors: David Weber, Ingrid Kane, Mike Rehal, Robert Lathrop, Kenny Aptekarev, Jeffrey Etter, Scott Whitcup